Sources | Names Used |
---|---|
CTRPv2 | ML334 diastereomer |
PharmacoGx | ML334 diastereomer |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OR4A16 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-06 |
mRNA | CCDC170 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-06 |
mRNA | OR8K1 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-06 |
mRNA | OR8U1 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-06 |
mRNA | LARP4 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |
mRNA | ZHX1 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-06 |
mRNA | ETFBKMT | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-06 |
mRNA | ZNF100 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
mRNA | OR5B21 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
mRNA | OR52A1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |